SARAH ELIZABETH PAGE

Art & Design

Breast Cancer Risk Assessment Tool

Breast Cancer Risk Assessment Tool


FBCP Logo

Familial Breast Cancer Program Logo


Breast Cancer Risk Assessment Tool - Welcome Page


Breast Cancer Risk Assessment Tool - Page 2 - General information


Breast Cancer Risk Assessment Tool - Page 3 - Ethnic Background


Breast Cancer Risk Assessment Tool - Page 4 - Reproductive History


Breast Cancer Risk Assessment Tool - Page 5 - Breast Biopsy History (if patient chooses "0", the next page will be skipped)


Breast Cancer Risk Assessment Tool - Page 6 - Breast Biopsy History


Breast Cancer Risk Assessment Tool - Page 7 - Family History of Breast or Ovarian Cancer (if patient chooses "no", the next page will be skipped)


Breast Cancer Risk Assessment Tool - Page 7 - Family History of Breast or Ovarian Cancer - Patient will fill this page out for each family member with a history of breast or ovarian cancer.


Final Results Page - This page will reveal the patient's results, score her on a visual risk scale, and allow the physician to invite her to participate in a long-term study.


Familial Breast Cancer Program Business Cards


Familial Breast Cancer Program, 2011-12

The logo design was created in September 2011 for the Familial Breast Cancer Program at the University of Illinois. The group offers services and information to patients that are at risk for breast cancer. In the design, I combined a DNA double helix with the ubiquitous pink ribbon.

I created the design for the Breast Risk Assessment Tool iPad application during the spring of 2012 at the University of Illinois at Chicago. The application was a part of a study to assess the risk of breast cancer in the general population. Data is entered in a few pages. After calcualations are made, three different risk scores are shown on a results page. The patient's risk is also graphically shown on a risk scale. Comments and recommendations for the patient are also reflected. The results page then allows the practitioner to invite the patient to enter a more involved study or not.